Abstract: The present invention relates to compounds of formula (I). The compounds may be used to modulate activity of the HPK-1 protein, and thereby treat cancer, viral infection and immune-mediated disorders.
| # | Name | Date |
|---|---|---|
| 1 | 202517049914-STATEMENT OF UNDERTAKING (FORM 3) [23-05-2025(online)].pdf | 2025-05-23 |
| 2 | 202517049914-REQUEST FOR EXAMINATION (FORM-18) [23-05-2025(online)].pdf | 2025-05-23 |
| 3 | 202517049914-PROOF OF RIGHT [23-05-2025(online)].pdf | 2025-05-23 |
| 4 | 202517049914-PRIORITY DOCUMENTS [23-05-2025(online)].pdf | 2025-05-23 |
| 5 | 202517049914-POWER OF AUTHORITY [23-05-2025(online)].pdf | 2025-05-23 |
| 6 | 202517049914-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [23-05-2025(online)].pdf | 2025-05-23 |
| 7 | 202517049914-FORM 18 [23-05-2025(online)].pdf | 2025-05-23 |
| 8 | 202517049914-FORM 1 [23-05-2025(online)].pdf | 2025-05-23 |
| 9 | 202517049914-DECLARATION OF INVENTORSHIP (FORM 5) [23-05-2025(online)].pdf | 2025-05-23 |
| 10 | 202517049914-COMPLETE SPECIFICATION [23-05-2025(online)].pdf | 2025-05-23 |
| 11 | 202517049914-FORM 3 [21-11-2025(online)].pdf | 2025-11-21 |